Today: 13 April 2026
Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

  • Movano is merging with Corvex, Inc. in an all‑stock deal that will transform Movano into a pure‑play AI infrastructure company. At close, the company will be renamed “Corvex, Inc.” and headquartered in Arlington, VA. PR Newswire
  • Ownership split (pre-financing adjustments): ~96.2% Corvex holders / 3.8% Movano holders; an earnout could deliver additional shares if future price milestones are met.
  • Financing in tandem with the deal: $37.1M raised by Corvex; Movano entered a $1.0B equity facility with Chardan and raised $3.0M bridge financing.
  • Legacy assets: Movano is permitted to market and sell its Evie‑brand wearables and RF technologies pre‑close, with potential net proceeds distributable to legacy Movano shareholders.
  • Stock reaction: MOVE shares spiked intraday following the announcement (live chart below).

What Happened

Movano Inc. (NASDAQ: MOVE) and Corvex, Inc., a GPU‑accelerated AI cloud company, signed a definitive all‑stock merger agreement. The combined business will focus squarely on secure, high‑performance AI infrastructure—including GPU clusters for training/inference, confidential computing, and inference‑as‑a‑service—repositioning Movano away from consumer health wearables. Upon closing, “Movano Inc.” will be renamed “Corvex, Inc.” and move its headquarters to Arlington, Virginia. PR Newswire

The boards of both companies have unanimously approved the transaction, which is targeted to close in Q1 2026, subject to customary approvals, Nasdaq listing conditions for the new shares, and the effectiveness of an S‑4 registration statement.


Deal Terms at a Glance

  • Structure: All‑stock merger; Corvex becomes a wholly owned subsidiary of Movano at close.
  • Ownership (pre‑adjustment): ~96.2% Corvex / 3.8% Movano on a fully‑diluted basis (excluding out‑of‑the‑money options and warrants). The ratio can adjust for concurrent financings and liabilities.
  • Valuation reference points: Exchange ratio reflects valuations of $250M for Corvex and $10M for Movano.
  • Earnout: Additional shares to Corvex stakeholders if the combined company achieves a $15.00 VWAP for 20 of 30 trading days by the 5th anniversary, and $25.00 by the 7th anniversary of closing.
  • Concurrent/related financing:
    • Corvex Concurrent Financing:$37.1M of equity capital.
    • Movano Bridge Financing:$3.0M via Series A preferred.
    • Chardan Equity Facility (“ChEF”): Up to $1.0B equity facility entered by Movano. PR Newswire
  • Capitalization (illustrative): ~48.7M shares outstanding anticipated at closing (excluding potential ChEF issuances).
  • Governance:Six‑member board expected; five designated by Corvex, one by Movano. Co‑CEOs Seth Demsey and Jay Crystal to lead, with Brian Raymond as CTO.
  • Support agreements / lock‑ups: Movano directors, officers, and certain holders representing ~21.2% of outstanding shares signed support agreements and 180‑day lock‑ups (subject to exceptions).
  • Termination fee: Under certain alternative‑transaction scenarios, Movano would owe $500,000.

Why It Matters

This deal pivots Movano from health wearables to enterprise AI infrastructure, placing it within the fast‑growing “neocloud” cohort building GPU‑rich compute for model training and secure inference. The segment has seen multi‑billion‑dollar capacity commitments and contracts in 2024–2025, underscoring robust demand for third‑party AI compute at scale. Barron’s+2Reuters+2

Corvex’s platform emphasizes confidential computing and flexible deployment models (multi‑tenant, single‑tenant, and on‑prem), targeting security‑sensitive AI builders. That focus—combined with white‑glove engineering and the ability to deliver power at “AI factory” scale—forms the strategic rationale for the merger. PR Newswire+2corvex.ai+2


What Changes for Movano’s Legacy Assets (Evie/EvieMED & RF IP)

Under the merger agreement, Movano may market and sell its current operating assets—including the EvieMED Ring (which previously obtained FDA 510(k) clearance for pulse oximetry) and mmWave RF technology for cuffless blood pressure and non‑invasive glucose monitoring—before closing. Net proceeds, after loan pay‑down and reserves, may be distributed to pre‑merger Movano shareholders at closing.


Timeline and Next Steps

  • SEC Filings: Movano will file a Form S‑4 with a joint proxy/prospectus; shareholder votes will be required.
  • Regulatory/Listing Conditions: Nasdaq listing approval for the merger‑related shares and standard closing conditions apply.
  • Target Close:Q1 2026 (subject to approvals and other customary conditions).

Market Reaction (Today)

MOVE traded sharply higher intraday following the announcement (see live chart above for the latest price, high/low, and volume). Coverage from financial outlets likewise highlighted the magnitude of the move and the transformative nature of the transaction.


Executive Commentary (From Today’s Announcement)

Company leaders framed the combination as a way to deliver reliable, secure AI compute at scale with a software‑driven approach that improves cost and performance efficiency for inference. Movano’s CEO said Corvex’s engineering depth and security posture make it “an indispensable partner” for target customer segments—hence the pivot to create a “pure‑play platform for secure AI infrastructure and high‑performance inference.” (Paraphrased from the joint release.) PR Newswire


The Bottom Line for Investors

  • The merger recasts MOVE as an AI‑infrastructure vehicle with a new leadership team and HQ, while offering potential upside tied to AI compute demand.
  • Dilution and ownership are substantial: Corvex holders will own the vast majority of the combined entity; earnout and financing structures add further moving parts.
  • The sale of Movano’s legacy assets could return net cash to pre‑merger shareholders, but outcomes depend on sale proceeds, liabilities, and closing conditions.

This article is for informational purposes only and does not constitute investment advice. Always do your own research and consider consulting a licensed financial advisor.


Sources & Filings (Nov. 10, 2025)

  • Joint press release: transaction terms, financing, rebrand/location, asset‑sale permission.
  • SEC Form 8‑K / 425: ownership split, valuations, earnout triggers, support/lock‑up agreements, closing conditions, termination fee.
  • Market coverage: stock reaction and additional reporting.
  • Corvex product context: platform positioning and offerings.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Telix Pharmaceuticals Shares Surge 13.1% on Regeneron Partnership and FDA Nod for TLX101-Px
    April 13, 2026, 12:50 AM EDT. Telix Pharmaceuticals (ASX:TLX) gained 13.1% after announcing a 50/50 global partnership with Regeneron Pharmaceuticals to co-develop next-gen cancer radiopharmaceuticals. The deal includes a US$40 million upfront payment and up to US$2.1 billion in milestones and royalties. The U.S. FDA also accepted Telix's New Drug Application for TLX101-Px (Pixclara), an imaging agent for brain cancer, granted Orphan Drug and Fast Track status, with a PDUFA decision expected by September 11, 2026. While these developments bolster Telix's transition from imaging to therapeutic applications, investors remain cautious over pricing pressure in PSMA imaging and execution risks in late-stage trials. Analysts forecast revenue reaching US$1.2 billion by 2029, implying a 72% upside from current prices.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.04.2026

13 April 2026
LIVEMarkets rolling coverageStarted: April 13, 2026, 12:00 AM EDTUpdated: April 13, 2026, 12:50 AM EDT Telix Pharmaceuticals Shares Surge 13.1% on Regeneron Partnership and FDA Nod for TLX101-Px April 13, 2026, 12:50 AM EDT. Telix Pharmaceuticals (ASX:TLX) gained 13.1% after announcing a 50/50 global partnership with Regeneron Pharmaceuticals to co-develop next-gen cancer radiopharmaceuticals. The deal includes a US$40 million upfront payment and up to US$2.1 billion in milestones and royalties. The U.S. FDA also accepted Telix's New Drug Application for TLX101-Px (Pixclara), an imaging agent for brain cancer, granted Orphan Drug and Fast Track status, with a PDUFA decision expected
Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend
Previous Story

Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend

Venture Global (VG) swings to Q3 profit on record LNG exports; unveils 20‑year Naturgy deal and trims 2025 guidance
Next Story

Venture Global (VG) swings to Q3 profit on record LNG exports; unveils 20‑year Naturgy deal and trims 2025 guidance

Go toTop